CTOs on the Move

Coast To Coast Respiratory

www.c2crespiratory.com

 
Coast To Coast Respiratory LLC is a Wilmington, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Caring People

Caring People offering 24 hour home care service for the elderly and help seniors daily living at home. Hire 24-hour caregivers for your loved one.

Systems Xcellence

Systems Xcellence, Inc is a Milton, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aware Health

Aware Health is a B2B partner that delivers modern solutions to self-insured employers to contain orthopedic claims costs.

East Coast Medical Systems

We bring many years of combined experience of equipment support, on-staff hospital imaging engineering and operations into a top-notch group of service and sales professionals. In-depth knowledge and customer focus is key. We handle all types of MRI and CT maintenance and services, including full system installation, rigging, de-installation, cold-head replacement and cryogen fills. These are just some of the reasons why leading hospitals and physician groups rely on East Coast Medical Systems to repair and service their imaging equipment.Our purpose is to express our diligence, knowledge and vigilance by pinpointing our customer`s needs and by addressing their problems, by hiring highly skilled engineers in order to provide an exact diagnosis and by being keenly watchful for any ensuing problems. To grow the organization properly, and maintain our reputation as being one of the highest regarded companies in our field, both by our customers and our peers.

scPharmaceuticals

scPharmaceuticals, based in Lexington, MA, is a privately held biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. Based on widely used generic drugs that currently require intravenous or intramuscular injections, our innovative products will be administered subcutaneously via a proprietary patch pump. This avoids material risks and costs associated with the current delivery options. Our lead products are the first subcutaneous formulations of furosemide (the most widely used parenteral diuretic in treating heart failure) and ceftriaxone (the most widely used parenteral antibiotic outside the hospital setting). Our novel furosemide formulation enables convenient anytime anywhere use, for example in an outpatient setting instead of the emergency room or other in-patient settings. For ceftriaxone and other antibiotics, subcutaneous administration eliminates the need for PICCs (peripherally inserted central catheters), which are associated with serious complications, frequent adverse events and high medical cost. For further information on how we are transforming the administration of parenteral drugs.